Jump to content

Triflunordazepam

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by OrganoMetallurgy (talk | contribs) at 18:02, 13 June 2017 (removed Category:Organofluorides; added Category:Trifluoromethyl compounds using HotCat). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Triflunordazepam
Clinical data
ATC code
  • none
Identifiers
  • 5-phenyl-7-(trifluoromethyl)-1,3-dihydro-1,4-benzodiazepin-2-one
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H11F3N2O
Molar mass304.267 g/mol g·mol−1
3D model (JSmol)
  • C1C(=O)NC2=C(C=C(C=C2)C(F)(F)F)C(=N1)C3=CC=CC=C3
  • InChI=1S/C16H11F3N2O/c17-16(18,19)11-6-7-13-12(8-11)15(20-9-14(22)21-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,21,22)
  • Key:UUBMOUNXQFMBQF-UHFFFAOYSA-N
  (verify)

Triflunordazepam (also known as Ro5-2904)[1] is a drug which is a benzodiazepine derivative with high GABAA receptor affinity, and has anticonvulsant effects.[2][3]

See also

References

  1. ^ DE Patent 1136709
  2. ^ Archives Internationales de Pharmacodynamie et de Thérapie. (1965). Vol 154, p 131.
  3. ^ So SS, Karplus M (December 1996). "Genetic neural networks for quantitative structure-activity relationships: improvements and application of benzodiazepine affinity for benzodiazepine/GABAA receptors". Journal of Medicinal Chemistry. 39 (26): 5246–56. doi:10.1021/jm960536o. PMID 8978853.